Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease
Authors:
- Marta Vicente-RodríguezMarta Vicente-Rodríguez
- Renzo MancusoRMRenzo Mancuso
- Alba Peris-YagueAPAlba Peris-Yague
- Camilla SimmonsCSCamilla Simmons
- Diego Gómez-NicolaDGDiego Gómez-Nicola
- V. Hugh PerryVPV. Hugh Perry
- Federico TurkheimerFTFederico Turkheimer
- Simon LovestoneSLSimon Lovestone
- Christine A. ParkerCPChristine A. Parker
- Diana CashDCDiana Cash
Open Access
- 9 April 2023
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 20 (1) , 1-14
Abstract
Neuroinflammation is an important component of many neurodegenerative diseases, whether as a primary cause or a secondary outcome. For that reason, either as diagnostic tools or to monitor progression and/or pharmacological interventions, there is a need for robust biomarkers of neuroinflammation in the brain. Mitochondrial TSPO (18 kDa Translocator protein) is one of few available biomarkers of neuroinflammation for which there are clinically available PET imaging agents. In this study, we further characterised neuroinflammation in a mouse model of prion-induced chronic neurodegeneration (ME7) including a pharmacological intervention via a CSF1R inhibitor. This was achieved by autoradiographic binding of the second-generation TSPO tracer, [3H]PBR28, along with a more comprehensive examination of the cellular contributors to the TSPO signal changes by immunohistochemistry. We observed regional increases of TSPO in the ME7 mouse brains, particularly in the hippocampus, cortex and thalamus. This increased TSPO signal was detected in the cells of microglia/macrophage lineage as well as in astrocytes, endothelial cells and neurons. Importantly, we show that the selective CSF1R inhibitor, JNJ-40346527 (JNJ527), attenuated the disease-dependent increase in TSPO signal, particularly in the dentate gyrus of the hippocampus, where JNJ527 attenuated the number of Iba1+ microglia and neurons, but not GFAP+ astrocytes or endothelial cells. These findings suggest that [3H]PBR28 quantitative autoradiography in combination with immunohistochemistry are important translational tools for detecting and quantifying neuroinflammation, and its treatments, in neurodegenerative disease. Furthermore, we demonstrate that although TSPO overexpression in the ME7 brains was driven by various cell types, the therapeutic effect of the CSF1R inhibitor was primarily to modulate TSPO expression in microglia and neurons, which identifies an important route of biological action of this particular CSF1R inhibitor and provides an example of a cell-specific effect of this type of therapeutic agent on the neuroinflammatory process.Keywords
Funding Information
- GlaxoSmithKline
This publication has 63 references indexed in Scilit:
- An analysis of the dentate gyrus functionBehavioural Brain Research, 2013
- Translocator Protein (18 kDa) Polymorphism (rs6971) Explains in-vivo Brain Binding Affinity of the PET Radioligand [18F]-FEPPAJournal of Cerebral Blood Flow & Metabolism, 2012
- Absence of Colony Stimulation Factor-1 Receptor Results in Loss of Microglia, Disrupted Brain Development and Olfactory DeficitsPLOS ONE, 2011
- An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28Journal of Cerebral Blood Flow & Metabolism, 2011
- Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brainNeuropathology and Applied Neurobiology, 2009
- Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS PathologiesJournal of Neuroscience, 2008
- Multiple Immunoenzyme Staining: Methods and Visualizations for the Observation With Spectral ImagingJournal of Histochemistry & Cytochemistry, 2007
- The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survivalClinical Neuroscience Research, 2006
- Role of the peripheral benzodiazepine receptor in sensory neuron regenerationMolecular and Cellular Neuroscience, 2005
- Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's diseaseNeuroscience Letters, 1998